PEP++: Enhanced chemoprophylaxis
Country: Brazil
Location(s): Fortaleza and Sobral
The PEP++ Program Starting in 2018, is a multicenter clinical research that is being developed in two cities in Ceará (Fortaleza and Sobral) and should generate evidence of the effectiveness of a reinforced chemoprophylaxis regimen for close contacts of people affected by leprosy. Additionally, research has been developed at PEP++ to study knowledge, practices, perceptions and attitudes, adding value to overcoming stigma and prejudice in addition to training professionals at Primary Health Centers. PEP++ is in the monitoring and evaluation phase of contacts who received chemoprophylaxis. It is expected that the results can influence national leprosy control policy, including chemoprophylaxis as a strategy.
ILEP Members involved
NLRAlexandre Menezes